Found: 2
Select item for more details and to access through your institution.
Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a γ-secretase inhibitor targeting notch signaling.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.
- Published in:
- 2009
- By:
- Publication type:
- journal article